Literature DB >> 18805694

Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.

Casey E Bohl1, Zengru Wu, Jiyun Chen, Michael L Mohler, Jun Yang, Dong Jin Hwang, Suni Mustafa, Duane D Miller, Charles E Bell, James T Dalton.   

Abstract

Selective androgen receptor modulators (SARMs) are essentially prostate sparing androgens, which provide therapeutic potential in osteoporosis, male hormone replacement, and muscle wasting. Herein we report crystal structures of the androgen receptor (AR) ligand-binding domain (LBD) complexed to a series of potent synthetic nonsteroidal SARMs with a substituted pendant arene referred to as the B-ring. We found that hydrophilic B-ring para-substituted analogs exhibit an additional region of hydrogen bonding not seen with steroidal compounds and that multiple halogen substitutions affect the B-ring conformation and aromatic interactions with Trp741. This information elucidates interactions important for high AR binding affinity and provides new insight for structure-based drug design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805694      PMCID: PMC2577784          DOI: 10.1016/j.bmcl.2008.09.002

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

2.  Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

Authors:  Donghua Yin; Yali He; Minoli A Perera; Seoung Soo Hong; Craig Marhefka; Nina Stourman; Leonid Kirkovsky; Duane D Miller; James T Dalton
Journal:  Mol Pharmacol       Date:  2003-01       Impact factor: 4.436

3.  Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats.

Authors:  Jeffrey D Kearbey; Wenqing Gao; Ramesh Narayanan; Scott J Fisher; Di Wu; Duane D Miller; James T Dalton
Journal:  Pharm Res       Date:  2006-10-25       Impact factor: 4.200

4.  Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.

Authors:  L Kirkovsky; A Mukherjee; D Yin; J T Dalton; D D Miller
Journal:  J Med Chem       Date:  2000-02-24       Impact factor: 7.446

5.  Pharmacodynamics of selective androgen receptor modulators.

Authors:  Donghua Yin; Wenqing Gao; Jeffrey D Kearbey; Huiping Xu; Kiwon Chung; Yali He; Craig A Marhefka; Karen A Veverka; Duane D Miller; James T Dalton
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

Review 6.  Androgen replacement therapy: present and future.

Authors:  Louis J G Gooren; Mathijs C M Bunck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.

Authors:  Craig A Marhefka; Wenqing Gao; Kiwon Chung; Juhyun Kim; Yali He; Donghua Yin; Casey Bohl; James T Dalton; Duane D Miller
Journal:  J Med Chem       Date:  2004-02-12       Impact factor: 7.446

8.  A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.

Authors:  Casey E Bohl; Cheng Chang; Michael L Mohler; Jiyun Chen; Duane D Miller; Peter W Swaan; James T Dalton
Journal:  J Med Chem       Date:  2004-07-15       Impact factor: 7.446

Review 9.  An integrative review on current evidence of testosterone replacement therapy for the andropause.

Authors:  Robert S Tan; John W Culberson
Journal:  Maturitas       Date:  2003-05-30       Impact factor: 4.342

10.  Testosterone supplementation: what and how to give.

Authors:  F Jockenhövel
Journal:  Aging Male       Date:  2003-09       Impact factor: 5.892

View more
  6 in total

1.  X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Bert Kazemier; Rolien Bosch; Ross McGuire; Rita Azevedo; Hans Hamersma; Koen Dechering; Arthur Oubrie; Marcel van Duin; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.

Authors:  Amanda Jones; Dong Jin Hwang; Charles B Duke; Yali He; Anjaiah Siddam; Duane D Miller; James T Dalton
Journal:  J Pharmacol Exp Ther       Date:  2010-05-05       Impact factor: 4.030

3.  The long and winding road for selective androgen receptor modulators.

Authors:  James T Dalton
Journal:  Br J Clin Pharmacol       Date:  2017-07-17       Impact factor: 4.335

4.  Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues.

Authors:  Min Pi; Karan Kapoor; Yunpeng Wu; Ruisong Ye; Susan E Senogles; Satoru K Nishimoto; Dong-Jin Hwang; Duane D Miller; Ramesh Narayanan; Jeremy C Smith; Jerome Baudry; L Darryl Quarles
Journal:  Mol Endocrinol       Date:  2015-10-06

Review 5.  Selective androgen receptor modulators: the future of androgen therapy?

Authors:  Andrew R Christiansen; Larry I Lipshultz; James M Hotaling; Alexander W Pastuszak
Journal:  Transl Androl Urol       Date:  2020-03

6.  Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors.

Authors:  Mariia Radaeva; Huifang Li; Eric LeBlanc; Kush Dalal; Fuqiang Ban; Fabrice Ciesielski; Bonny Chow; Helene Morin; Shannon Awrey; Kriti Singh; Paul S Rennie; Nada Lallous; Artem Cherkasov
Journal:  Cells       Date:  2022-09-07       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.